Integragen (XPAR:ALINT) EV-to-OCF: (As of Aug. 15, 2026)

Integragen  (XPAR:ALINT) EV-to-OCF Explanation

EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Integragen's PE Ratio (TTM) for today is calculated as:

Integragen's share price for today is €0.1975.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Integragen's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2025 was €-0.234.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.

Integragen EV-to-OCF Related Terms

The historical data trend for Integragen's EV-to-OCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Integragen EV-to-OCF Chart

Integragen Annual Data
	Trend	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23	Dec24	Dec25
EV-to-OCF		Get a 7-Day Free Trial					0.00	0.00	0.00	0.00	0.00

Integragen Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24	Jun25	Dec25
EV-to-OCF	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

XPAR:ALINT vs VRTX, REGN, RVMD: EV-to-OCF Comparison

For the Biotechnology subindustry, Integragen's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Integragen EV-to-OCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Integragen's EV-to-OCF distribution charts can be found below:

* The bar in red indicates where Integragen's EV-to-OCF falls into.

Integragen EV-to-OCF Calculation

Integragen's EV-to-OCF for today is calculated as:

Integragen's current Enterprise Value is €0.50 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Integragen's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2025 was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Integragen Business Description